Ayrton Bangolo | Oncology | Best Researcher Award

Posted on 18/11/202418/11/2024 by ScienceFather

Dr. Ayrton Bangolo | Oncology | Best Researcher Award

Dr at Hackensack University Medical Center, United States

Dr. Ayrton I. Bangolo, MBBS, MD, is a board-certified internal medicine physician and current Hematology and Oncology fellow at Hackensack University Medical Center, New Jersey. With extensive medical training spanning across multiple countries, he graduated from Tianjin Medical University in China with an MBBS and gained ECFMG certification after excelling in USMLE exams. Dr. Bangolo has held significant positions in various esteemed medical institutions, including a residency at Palisades Medical Center, NJ. He has showcased his expertise through clinical practice, externships, and observerships in internal medicine, endocrinology, nephrology, and interventional radiology. His dedication to research and community health has been recognized with accolades such as awards at HMH research day. Dr. Bangolo’s background is enriched with a global perspective, which contributes to his comprehensive approach to patient care and medical innovation.

Profile

Scholar

Education 🎓

Ph.D. Fellowship in Hematology and Oncology (2024-Present): Hackensack University Medical Center, NJ, enrolled in an ACGME-accredited program. Residency in Internal Medicine (2021-2024): Palisades Medical Center, North Bergen, NJ, successfully completed a full-term ACGME-accredited residency. Transitional Year Residency (2020-2021): Palisades Medical Center, NJ, completed with exemplary performance. MBBS Degree (June 2016): Tianjin Medical University, China, graduated with credentials equivalent to MD. USMLE Certification: Passed USMLE Steps 1, 2 CK, and 3 on the first attempt, affirming ECFMG certification and eligibility for medical licensure in the U.S. Externships and Observerships: Clinical experience at Endocrine Associates, Norton’s Suburban Hospital, and Ngaliema Clinic among others, contributing to multidisciplinary expertise in internal medicine and specialty areas.

Experience 💼

Hematology and Oncology Fellow (2024-Present): Hackensack University Medical Center, NJ, contributing to advanced clinical research and patient care in an ACGME-accredited fellowship. Internal Medicine Residency (2021-2024): Palisades Medical Center, North Bergen, NJ, completed core rotations with a focus on comprehensive patient care. Transitional Year Residency (2020-2021): Provided care across multiple medical disciplines at Palisades Medical Center, NJ. Externship in Endocrinology (2019-2020): Engaged in specialized practice under Dr. Hisham Alrefai at Endocrine Associates, KY. Observership in Nephrology (2019): Gained nephrology insights with Dr. Mohammed El Kheir at Norton’s Suburban Hospital, KY. Interventional Radiology Observership (2019): Participated under Dr. Mahmoud Samman, contributing to a deeper understanding of interventional procedures. Clinical Clerkship (2015-2016): Acquired foundational medical practice skills at Ngaliema Clinic, DR Congo.

Awards and Honors 🏆

2nd Place Research Poster: Honored for the study “Racial/Ethnic and Socioeconomic Differences in Colon Cancer Surgery” during the HMH North Region Fellow/Residents Research Day. UN Sustainable Development Goals Contribution: Published impactful research with Elsevier (2019-2021), emphasizing global health initiatives. Recognition for Excellence: Commended for clinical contributions during externships and observerships in Kentucky. Top Medical Graduate: Recognized as a distinguished graduate from Tianjin Medical University. USMLE Success: Passed all USMLE examinations on the first attempt, underscoring strong academic and practical medical knowledge.

Research Focus 🔍

Hematology & Oncology: Ongoing research in treatment protocols and health disparities, focusing on patient outcomes and innovative care practices. Racial and Socioeconomic Health Disparities: Investigated disparities in surgical treatments for colon cancer, contributing to policy discussions and medical strategies. Global Health Contributions: Published research aligning with United Nations’ goals, influencing international health practices. Medical Imaging & Diagnostics: Explored advancements in imaging for early disease detection and effective management. Endocrinology & Nephrology: Applied deep learning to medical data for better diagnostic outcomes and patient treatment plans. Patient Care & Clinical Innovation: Emphasizes integrative methods in patient treatment, fostering evidence-based and empathetic healthcare practices.

Conclusion 📝

Dr. Ayrton I. Bangolo’s proven track record in clinical practice, research contributions, and scholarly publications position him as a strong contender for the Best Researcher Award. His focus on impactful research and addressing health disparities is commendable. By expanding his research collaborations and further emphasizing his mentorship roles, Dr. Bangolo’s candidacy would be even more compelling.

Publications 📚

Title: Ultrasound performance using the EU-TIRADS score in the diagnosis of thyroid cancer in Congolese hospitals
Authors: J Bukasa-Kakamba, P Bayauli, N Sabbah, J Bidingija, A Atoot, B Mbunga, …
Year: 2022
Journal: Scientific Reports 12 (1), 18442
Citations: 9

Title: Racial/ethnic and socioeconomic differences in breast cancer surgery performed and delayed treatment: mediating impact on mortality
Authors: P Fwelo, KOS Nwosu, TE Adekunle, O Afolayan, O Ahaiwe, AA Ojaruega, …
Year: 2023
Journal: Breast Cancer Research and Treatment 199 (3), 511-531
Citations: 7

Title: Epidemiologic risk factors for patients admitted with chronic pancreatitis and pancreatic ductal adenocarcinoma in the United States
Authors: D Lew, F Kamal, K Phan, K Randhawa, S Cornwell, AI Bangolo, …
Year: 2022
Journal: World Journal of Clinical Oncology 13 (11), 907
Citations: 7

Title: Impact of gut microbiome in the development and treatment of pancreatic cancer: Newer insights
Authors: AI Bangolo, C Trivedi, I Jani, S Pender, H Khalid, B Alqinai, A Intisar, …
Year: 2023
Journal: World Journal of Gastroenterology 29 (25), 3984
Citations: 6

Title: Primary cardiac sarcoma: clinical characteristics and prognostic factors over the past 2 decades
Authors: A Bangolo, P Fwelo, KM Iyer, S Klinger, L Tavares, S Dey, AA Chacko, …
Year: 2023
Journal: Diseases 11 (2), 74
Citations: 6

Title: The overall quality of evidence of recommendations surrounding nutrition and diet in inflammatory bowel disease
Authors: S Weissman, BM Fung, A Bangolo, A Rashid, BF Khan, AKG Tirumala, …
Year: 2023
Journal: International Journal of Colorectal Disease 38 (1), 98
Citations: 6

Title: The Spectrum of Thyroid Nodules at Kinshasa University Hospital, Democratic Republic of Congo: A Cross-Sectional Study
Authors: JK Bukasa, P Bayauli-Mwasa, BK Mbunga, A Bangolo, W Kavula, …
Year: 2022
Journal: International Journal of Environmental Research and Public Health 19 (23), 16203
Citations: 6

Title: Outcomes of patients with gastrointestinal stromal tumors in the past decade
Authors: A Bangolo, P Fwelo, T Al-Qatish, J Bukasa-Kakamba, T Lee, AG Cayago, …
Year: 2023
Journal: Medical Sciences 11 (3), 54
Citations: 5

Muthyam Sowjanya |Cancer | Women Researcher Award

Posted on 15/11/2024 by ScienceFather

Dr. Muthyam Sowjanya | Cancer | Women Researcher Award

Dr at Vikrama simhapuri university, India

Sowjanya Muthyam, Ph.D., is a dedicated and highly skilled scientist with 8 years of expertise in immunology, inflammation, molecular biology, cell biology, and biochemistry. Having worked on diverse research projects, including promoting polythene degradation by Spingomonas bacteria and studying bioactive compound production from fungi, Dr. Muthyam seeks a Scientist position to advance industrial, clinical, and translational research.

Profile

Orcid

Education 🎓

Dr. Muthyam holds a Ph.D. in Biotechnology from Andhra University (2014-2019), where her thesis focused on isolating, purifying, and characterizing novel anticancer compounds from Leucas indica flowers. She also completed her M.Sc. in Biotechnology from SRM University (2009-2011), where she studied shell loss in P. monodon and the antiglycation effects of spices. She holds a B.Sc. in Biotechnology, Chemistry, and Computer Applications from Sri Venkateswara University (2006-2009).

Research Experience 💼

Dr. Muthyam’s doctoral research involved isolating and characterizing bioactive compounds from Leucas indica, revealing an anticancer compound that inhibited cancer cell proliferation, particularly in MCF-7 and HeLa cell lines. Her work involved various techniques like column chromatography, UV, TLC, NMR, and apoptosis assays, contributing significantly to cancer treatment strategies. She also collaborated on projects related to bioremediation and bioactive compound production.

Awards 🏆

Dr. Muthyam has received the UGC RGNF fellowship as a Junior Research Fellow (2014-2016) and a Senior Research Fellow (2016-2019). She has also mentored graduate and undergraduate students, supervised research projects, and served as a judge for research poster presentations. Her contributions to the field have earned recognition within the scientific community, particularly for her work on novel anticancer compounds.

Research Focus 🔍

Dr. Muthyam’s primary research focuses on the isolation and characterization of bioactive compounds, with a strong emphasis on anticancer agents. Her work also explores bioremediation strategies, enzyme production, and the application of fungi in industrial processes. Dr. Muthyam is particularly interested in advancing molecular biology, immunology, and biochemistry to develop therapeutics for cancer treatment and environmental sustainability.

Teaching and Mentoring Experience🧑‍🏫

Dr. Muthyam has a solid background in teaching and mentoring, having supervised over 40 graduate students and interns at Andhra University. She has also mentored numerous undergraduate students and evaluated their research poster presentations. Additionally, she is currently serving as a guest faculty member at Vikrama Simhapuri University, where she continues to guide students in research and development.

Conclusion 📝

Dr. Sowjanya Muthyam stands out as a promising researcher with a solid academic foundation, innovative research achievements, and a passion for mentoring the next generation of scientists. Her work, particularly in cancer treatment and bioactive compounds, holds immense potential for future clinical and industrial applications. By focusing on expanding her publication record, collaborations, and public engagement, she can significantly enhance her impact in the scientific community. Dr. Muthyam is a strong candidate for the Women Researcher Award, and her continued contributions will undoubtedly advance the fields of biotechnology and molecular medicine.

Publications 📚

Probiotics Contribution to the Development of Aquaculture: A Review
- Journal: African Journal of Biological Sciences
- Date: 2024-07-20
- Contribution: Sowjanya Muthyam

Immobilisation of Aspergillus flavus Strain S4 Spores for Optimal Production and Activity of L-Glutaminase
- Journal: Chelonian Conservation and Biology
- Date: 2023-11-11
- Contribution: Sowjanya Muthyam

Incidence of White Feces Syndrome (WFS) and Its Management with Herbal Supplements (Allium sativum and Curcuma longa) by Improving the Growth and Gut Health of Shrimp Litopenaeus vannamei (Boone-1931)
- Journal: IJFANS International Journal of Food and Nutritional Sciences
- Date: 2023-11-11
- Contribution: Sowjanya Muthyam

Industrial Applications of Alkaline Protease with Novel Properties from Bacillus cereus Strain S8
- Date: 2023-11-07
- Contribution: Sowjanya Muthyam

Phytochemical Analysis and Antimicrobial Activity of Muntingia calabura
- Journal: Journal of Chemical Health Risks
- Date: 2023-11-07
- Contribution: Sowjanya Muthyam

Characterization of Alkaline Protease from Bacillus cereus Strain S8 by In Silico Approach
- Journal: Chelonian Conservation and Biology
- Date: 2023-11-02
- Contribution: Sowjanya Muthyam

In Vitro Antibacterial Activity of Flower Extract of Leucas indica
- Journal: Journal of Advanced Zoology
- Date: 2023-11-02
- Contribution: Sowjanya Muthyam

Antiglycation Effect of Chillies and Spices Used in Traditional Indian Cuisine
- Journal: European Journal of Biomedical and Pharmaceutical Sciences
- Date: 2023-10-22
- Contribution: Sowjanya Muthyam

Purification, Characterization Studies of L-Glutaminase from Aspergillus flavus Strain S4
- Journal: Journal of Advanced Zoology
- Date: 2023-10-01
- Contribution: Sowjanya Muthyam

Probiotics and Their Prolific Role in Shrimp Farming Practices

Date: 2022-12-26
Contribution: Sowjanya Muthyam

TANUMA MISTRY | CLINICAL ONCOLOGY | Best Researcher Award

Posted on 02/07/2024 by ScienceFather

Dr. TANUMA MISTRY | CLINICAL ONCOLOGY | Best Researcher Award

Ms at CHITTARANJAN NATIONAL CANCER INSTITUTE, India

Tanuma Mistry is a dedicated research fellow in the Department of Pathology and Cancer Screening at Chittaranjan National Cancer Institute, Kolkata, India. She holds a Master of Science in Zoology from the University of Calcutta, with extensive research experience in life sciences, specifically cancer research. Tanuma has received prestigious awards, including the SERB International Travel and CSIR-Foreign Travel Grant. She is a member of notable societies such as ESMO, ASCO, and AACR. Tanuma’s research focuses on molecular techniques and targeted therapeutics, contributing significantly to various high-impact publications in the field of oncology.

profile

Scopus

Academic Qualification:🎓

Master of Science (2016): M.Sc. in Zoology from University of Calcutta, Kolkata, India. Marks obtained: 75.1%. Bachelor of Science (2013):
B.Sc. in Zoology from University of Calcutta (Vidyasagar College for Women), Kolkata, India. Marks obtained: 68%. Higher Secondary Examination (10+2): West Bengal Council of Higher Secondary Education (WBCHSE), Kolkata, India. Ariadaha Sarbamangala Balika Vidyalaya
Marks obtained (Best of 4): 70.75%. Secondary Examination (10): West Bengal Board of Secondary Education (WBBSE), Kolkata, India.
Ariadaha Sarbamangala Balika Vidyalaya Marks obtained: 71.75%

Other Qualification:🧬

CSIR NET-JRF (June 2018) in Life Science (AIR-118). West Bengal State Eligibility Test (WBSET) 2018 in Life Science The Graduate Aptitude Test in Engineering (GATE)-XL 2022 in Life Science

Awards:🏅

SERB International Travel: ESMO Asia Congress 2023, Singapore. CSIR-Foreign Travel Grant: EBCC-13; Barcelona, Spain. 13th East Zonal Oncology Symposium 2024: 2nd Position in Poster Presentation

Membership of Societies:

The Zoological Society, Kolkata, European Society of Medical Oncology (ESMO) [Id: 561295], 🇺🇸 American Society of Clinical Oncology (ASCO) [Id: 7278374], American Association for Cancer Research (AACR) [Id: 1304687]

Research Experience:🔬

2019 – Till Date: CSIR Research Fellow Department of Pathology & Cancer Screening, Chittaranjan National Cancer Institute
Registered under Jadavpur University, Department of Life Science and Biotechnology, Kolkata, India

Skills in Laboratory Techniques:

Molecular techniques: Isolation of DNA, RNA, and Protein, PCR, RFLP, RT-PCR, Electrophoresis, Immunohistochemistry, Western Blotting, Northern Blotting, Southern Blotting, DNA sequencing, MTT assay. Computational skills: Operating systems: Windows, Mac Software: Microsoft Office, Statistical Software Sigma Graph & Plot, GraphPad Prism, SPSS, Mendeley, EndNote

Review during M.Sc:

Behavioral Ecology and Conservation Strategies of Greater One-horned Rhinoceros (Rhinoceros unicornis):
Under the Supervision of Dr. Rakesh Tamang

Project during M.Sc:

Localized Survey of Two Important Bio-resources (TEA & FISH) Types and Practices at Dooars Region of North Bengal:
Under the Supervision of Dr. Sumit Homechoudhury

Publications Top Notes

Title: Emerging futuristic targeted therapeutics: A comprising study towards a new era for the management of TNBC
Authors: Mistry T, Nath A, Pal R, Ghosh S, Sahoo PK, Mahata S, Sarkar S, Choudhury T, Nath P, Alam N, Nasare VD
Year: 2024
Title: Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer
Authors: Nath A, Mitra S, Mistry T, Pal R, Nasare VD
Year: 2021
Journal: Medical Oncology
DOI: 10.1007/s12032-021-01610-x

Title: Mitotic checkpoint defects: en route to cancer and drug resistance
Authors: Sarkar S, Sahoo PK, Mahata S, Pal R, Ghosh D, Mistry T, Ghosh S, Bera T, Nasare VD
Year: 2021
Title: PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer
Authors: Mahata S, Sahoo PK, Pal R, Sarkar S, Mistry T, Ghosh S, Nasare VD
Year: 2022
Journal: Medical Oncology
Title: Assessment of quality of life among advanced ovarian cancer patients in a tertiary care hospital in India
Authors: Sarkar S, Sahoo PK, Pal R, Mistry T, Mahata S, Chatterjee P, Vernekar M, Mandal S, Bera T, Nasare VD
Year: 2022
Title: Premalignant and malignant lesions of oral cavity in eastern India: a hospital-based study
Authors: Sahoo PK, Sarkar S, Ghosh D, Mahata S, Pal R, Mistry T, Ghosh S, Roy A, Bucha H, Mandal S, Nasare VD
Year: 2021
Title: Outcome of 3-year follow-up with induction vs first line chemotherapy in oral cancer patients: An observational hospital-based study
Authors: Sahoo PK, Bhowmick AK, Sarkar S, Mahata S, Pal R, Mistry T, Ghosh S, Choudhury T, Kumar RS, Mandal S, Datta S, Nath P, Mukherjee KK, Nasare VD
Title: Polymorphism of transporter genes contributes to variations in treatment outcomes and adverse events in platinum-based chemotherapy-treated oral cancer patients
Authors: Sahoo PK, Mistry T, Sarkar S, Ghosh D, Mahata S, Pal R, Ghosh S, Roy A, Bucha H, Mandal S, Datta S, Nasare VD
Year: 2024
Title: Impact of Low BMI and Nutritional Status on Quality of Life and Disease Outcome in Breast Cancer Patients: Insights from a Tertiary Cancer Center in India
Authors: Mistry T, Pal R, Ghosh S, Choudhury T, Mandal S, Nath P, Alam N, Nasare VD
Year: 2024

Angelika Długosz-Pokorska | cancer research | Women Researcher Award

Posted on 11/06/2024 by ScienceFather

Dr. Angelika Długosz-Pokorska | cancer research |Women Researcher Award

Dr at Medical University of Łódź, Poland

A dedicated researcher and project leader at the Medical University of Lodz, Poland, with expertise in pharmacological characterization and anticancer drug development. As Principal Investigator and Co-investigator, led projects funded by prestigious grants like OPUS and SONATA, focusing on opioid peptide analogs and alpha-methylidene-delta-lactones. Supervising international student exchanges and engaging in expert activities, workshops, and editorial work. Recognized with numerous awards for scientific excellence, including Rector’s Awards and IF=8.638 for publication series on opioid mimetics and glutathione peroxidase. Committed to advancing medical science through innovative research and academic leadership.

Profile

Scopus

Orcid

📜 Employment History:

Research Associate (2017-present) Medical University of Lodz, Poland; Faculty of Medicine. Co-investigator (2016-2021)
Project: Rational design and pharmacological characterization of chimeric cyclic opioid peptide analogs targeting multiple receptors
Grant: OPUS 9, project ID 2015/17/B/ST5/00153. Principal Investigator (2016-2021) Project: Analysis of the anticancer activity of new synthetic alpha-methylidene-delta-lactones in selected cell lines Grant: SONATA, project ID 2015/17/D/NZ3/02226. Supervisor, Project Manager, and Principal Investigator (2018-present) Project: Analysis of the anticancer activity and molecular mechanism of action of new hybrid molecules containing uracil skeleton with an exo-cyclic methylene group Grant: PRELUDIUM13, project ID UMO-2017/25/N/NZ3/01039

📚 Short Research Training:

University of Rouen, France (2014) Laboratoire de Neuropsychopharmacologie Expérimentale

🌍 Activities:

Expert Activity/Reviewer (2024)
Platform: Qeios
International Student Exchanges and ERASMUS Supervision (2024)
Engaging in initiatives and participating in European Union programs, overseeing ERASMUS students.
Participation in Scientific Workshops and Research Teams (2024)
Engaging in workshops aimed at exchanging experiences, self-improvement, and organization.
Editorial Work (2023-present)
Journal: Reviewer for Breast Cancer-Tokyo, ISSN 1340-6868, eISSN 1880-4233.

🏆 Awards and Distinctions:

2022: First-level Special Award for Outstanding Didactic Work by Academic Teachers Medical University of Lodz.

2020: Team Distinction from the Faculty of Chemistry Nicolaus Copernicus University in Toruń Rector’s Award Medical University of Lodz Second-degree scientific award for a series of publications titled: ‘Investigation of the Anticancer Properties of Synthetic Analogues of Compounds Isolated from Plants’. (Impact Factor – 8.034). Polish Intelligent Development Award – Nomination.

2019: Investigation of Anticancer Activity of Synthetic Analogues of Methylenolactones”, IF=4.026PTBioch Bursary Scholarship 44th FEBS Congress “From Molecules to Living Systems”. Rector’s Award Medical University of Lodz Second Prize for Publication: ‘Synthetic Analogues of Coumarin as Novel Agents with Anticancer Activity’. (Impact Factor = 4.173). Rector’s Award Medical University of Lodz Team Second award for Publication Series:

2017: Rector’s Award Medical University of Lodz First Prize for Publication Series: “Synthesis and Investigation of Biological Activity of Opioid Mimetics and Glutathione Peroxidase”. (IF=8.638). Rector’s Award Medical University of Lodz Team First Prize for Publication Series: “Anticancer Properties of Novel Synthetic Dicoumarins”. (IF=6.221) “Investigation of Anticancer Activity of Sesquiterpene Lactones”. (IF=4.994)

2016: Rector’s Award Medical University of Lodz First Prize for Publication Series: “Anticancer Properties of Novel Synthetic Lactones in Combination with Known Anticancer Drugs”. (IF = 8.835)

Publications Top Notes 📝

Title: Synthesis of New Chiral β-Carbonyl Selenides with Antioxidant and Anticancer Activity Evaluation-Part I
- Authors: Laskowska, A., Pacuła-Miszewska, A.J., Obieziurska-Fabisiak, M., et al.
- Journal: Materials
- Year: 2024
- Volume: 17
- Pages: 1–15
- Summary: This study focuses on the synthesis of new chiral β-carbonyl selenides and evaluates their antioxidant and anticancer activities, providing valuable insights into potential therapeutic agents.

Title: New Uracil Analog with Exocyclic Methylidene Group Can Reverse Resistance to Taxol in MCF7 Cancer Cells
- Authors: Długosz-Pokorska, A., Perlikowska, R., Janecki, T., et al.
- Journal: Biologics: Targets and Therapy
- Year: 2023
- Volume: 17
- Pages: 69–83
- Summary: This article presents a novel uracil analog with potential to reverse resistance to Taxol in MCF7 cancer cells, indicating its promising role as an anticancer agent.

Title: New Uracil Analog- U-359 can Reverse Resistance to Taxol in MCF-7 cancer cells
- Authors: Długosz-Pokorska, A., Perlikowska, R., Janecki, T., et al.
- Journal: Acta Biochimica Polonica
- Year: 2023
- Volume: 70
- Pages: 56
- Summary: This study explores another uracil analog’s potential to reverse resistance to Taxol in MCF-7 cancer cells, indicating a promising avenue for further research.

Title: The Influence of Long Carbon Chains on the Antioxidant and Anticancer Properties of N-Substituted Benzisoselenazolones and Corresponding Diselenides
- Authors: Pacuła-Miszewska, A.J., Obieziurska-Fabisiak, M., Jastrzębska, A., et al.
- Journal: Pharmaceuticals
- Year: 2023
- Volume: 16
- Pages: 1–11
- Summary: This research investigates the impact of long carbon chains on the antioxidant and anticancer properties of N-substituted benzisoselenazolones and corresponding diselenides, providing valuable insights into structure-activity relationships.

Title: Attachment of Chiral Functional Groups to Modify the Activity of New GPx Mimetics
- Authors: Laskowska, A., Pacuła-Miszewska, A., Długosz-Pokorska, A., et al.
- Journal: Materials
- Year: 2022
- Volume: 16
- Pages: 1–14
- Summary: This study explores the modification of GPx mimetics’ activity through the attachment of chiral functional groups, offering potential strategies for enhancing therapeutic effects.

Teng Zhang | Gynecologic Oncology | Young Scientist Award

Posted on 27/05/202428/05/2024 by ScienceFather

Ms. ‌Teng Zhang |Gynecologic Oncology |Young Scientist Award

Ms at Qilu Hospital of Shandong University, China

Ms. Teng Zhang is an accomplished Attending Doctor in the Department of Obstetrics and Gynecology at Qilu Hospital of Shandong University. With a Ph.D. and Master’s degree from Cheeloo College of Medicine, Shandong University, and a Bachelor’s degree from Jining Medical College, Ms. Zhang has extensive experience in clinical practice and research. Notable achievements include publications on cervical cancer in high-impact journals and awards in English teaching competitions. Dr. Zhang’s research focuses on fertility-sparing treatments, m6A methylation, and immune cell variations in cervical cancer, underscoring a strong commitment to advancing women’s health.

Profile

Scopus

🎓 Education Background

Sept. 2015 – Sep. 2018: Ph.D., Cheeloo College of Medicine, Shandong University. Sept. 2013 – Sep. 2015: Master, Cheeloo College of Medicine, Shandong University. Sept. 2008 – Jun. 2013: Bachelor of Medicine, Jining Medical College. Sept. 2005 – Jun. 2008: Qingdao No.2 Middle School

💼 Research/Work Experience

July 2022 – Present: Attending Doctor, Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University. Nov. 2018 – June 2021: Resident, Department of Gynecology and Obstetrics, Qilu Hospital of Shandong University. June 2016 – June 2017: Visiting Scholar, Griffith University, Australia

🏆 Scholarships and Awards

2023: Young Teachers English Teaching Competition, Second Prize, Cheeloo College of Medicine, Shandong University, 2021: The First “Guangzhi Cup” English Teaching Competition in Qilu Hospital of Shandong University, Third Prize, July 2013: Excellent Graduate of Shandong Province, Oct. 2009: National Scholarship

Publications Top Notes 📝

Xuji Jiang, Chuanli Feng, Wanying Sun, Teng Zhang*, Baoxia Cui. “The top 100 most cited articles on fertility-sparing treatments for cervical cancer: A bibliometric analysis.” Heliyon, 10(11), 2024.

Zhonghao Mao, Bingyu Wang, Teng Zhang, Baoxia Cui*. “The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications.” Cell Death and Disease, 2023, 14(734).

Teng Zhang, Jun Jiao, Xinlin Jiao, Lu Zhao, Xinli Tian, Qing Zhang, Daoxin Ma, Baoxia Cui*. “Aberrant frequency of TNFR2+ Treg and related cytokines in patients with CIN and cervical cancer.” Oncotarget, 2017, 9(4).

Bingyu Wang, Zhonghao Mao, Jinwen Ye, Xinlin Jiao, Teng Zhang, Qi Wang, Sai Han, Youzhong Zhang, Chunling Wang, Taotao Dong, Baoxia Cui. “Glycolysis Induced by METTL14 Is Essential for Macrophage Phagocytosis and Phenotype in Cervical Cancer.” The Journal of Immunology, 2024, 15(212).

Zhang W, Tian X, Mumtahana F, Jiao J, Zhang T, Croce K.D., Cui B*. “The existence of Th22, pure Th17 and Th1 cells in CIN and Cervical Cancer along with their frequency variation in different stages of cervical cancer.” BMC Cancer, 2015, 15,717.

Jun Jiao, Teng Zhang, Xinlin Jiao, Tingting Huang, Lu Zhao, Daoxin Ma, Baoxia Cui*. “hsa_circ_0000745 promotes cervical cancer by increasing cell proliferation, migration, and invasion.” J Cell Physiol, 2019, 1-9.

Xinlin Jiao, Siying Zhang, Jun Jiao, Teng Zhang, Wenjie Qu, Guy Mutangala Muloye, Beihua Kong, Qing Zhang, Baoxia Cui*. “Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance.” Clin Epigenetics, 2019, 11(120).